abstract |
The present invention provides compounds of Formula (1) and pharmaceutically acceptable salts, solvates, esters, and tautomers thereof, s wherein: Q is selected from the group consisting of: (a), (b), (c), (d) and (e); and L is selected from the group consisting of: (f), (g), (h), and (i); pharmaceutically compositions comprising one or more compounds of formula (I), and methods of using the compounds of formula (1). w:\nrportbl\GHMatters\KIRSTENA\4245447_1.DOCX11/04/13 |